Acute Care Syndromic Testing Market to grow with a CAGR of 6.91% through 2030
Initiatives taken by the government to support syndromic testing programs is expected to drive the Global Acute Care Syndromic Testing Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Acute
Care Syndromic Testing Market –Global Industry Size, Share, Trends,
Competition, Opportunity and Forecast, 2030F”, Global Acute Care
Syndromic Testing Market was valued at USD 3.12 billion in 2024 and is
anticipated to project robust growth in the forecast period with a CAGR
of 6.91% through 2030. the Global Acute Care
Syndromic Testing Market is anticipated to register a high CAGR during the
forecast period. This can be ascribed to collaborations and partnerships among
leading companies with a diverse approach to merge the expertise of individual
companies and to strengthen their position in the market.
Dyes are used to identify the underlying cause
of a patient's symptoms, which can help to guide treatment and improve patient
outcomes. Syndromic testing can be used to diagnose a wide range of conditions.
Significant increase in infectious diseases in the healthcare industry across
the globe represents one of the key factors creating a positive outlook for the
market. Furthermore, the increasing demand for point-of-care-testing and
growing focus on preventive healthcare among individuals is also driving the
market growth. Acute care syndromic testing is typically conducted in various
healthcare settings where patients require immediate medical attention and
rapid diagnostic results. These settings are equipped to diagnose and manage
acute medical conditions, infectious diseases, and emergencies. Such growing
global disease burden and the demand of rapid diagnosis use of Acute care
syndromic testing lead to the increasing demand for testing.
Leading players operating in
the industry are focusing on diagnosis innovations to offer a better customer
experience. They are also engaging in partnerships and collaborations to
increase their brand presence. Apart from this, People prefer acute care
syndromic testing for several reasons, primarily due to its ability to provide
rapid, comprehensive, and accurate diagnostic information in acute medical
situations. Moreover, Acute care syndromic testing offers rapid results,
allowing healthcare providers to diagnose and initiate appropriate treatment
quickly. Timely interventions can lead to better patient outcomes and prevent
complications. This, along with the rising demand for Rapid and accurate
diagnosis is crucial in acute medical situations to initiate appropriate
treatment promptly.
Acute care syndromic testing meets this demand by providing
quick results, allowing healthcare providers to make informed decisions. There
is a growing emphasis on Point-of-Care Testing practices within the healthcare
industry, with developing and expanding point-of-care syndromic testing
solutions. These enable immediate testing and decision-making at or near the
patient's location, reducing turnaround times and improving patient outcomes.
These methods aim to provide rapid and convenient diagnostic results at or near
the patient's location. The primary goal of POCT is to enable healthcare
providers to make timely clinical decisions, initiate appropriate treatments,
and improve patient outcomes. By eliminating the need to send samples to
centralized laboratories, POCT reduces turnaround times for test results. This
speed is crucial for guiding immediate patient management.
Browse over XX market data Figures and spread through 110 Pages and an in-depth TOC on "Global
Acute Care Syndromic Testing Market.”
The Global Acute Care Syndromic Testing Market
segmentation is based on Disease Type, Target, Sample Type, End User, By
Company, and Region.
Based on disease type, respiratory diseases are expected to grow at the fastest rate in the acute care syndromic testing market due to their high global prevalence and the urgent need for rapid diagnosis in clinical settings. Conditions like influenza, COVID-19, respiratory syncytial virus (RSV), and pneumonia often present with similar symptoms, making syndromic panels essential for differentiating between pathogens. The increasing burden of respiratory infections, particularly during seasonal outbreaks and pandemics, drives the demand for multiplex testing that can deliver results within hours. Additionally, advancements in PCR-based respiratory panels and growing adoption in emergency departments further contribute to the segment’s rapid growth, enabling timely intervention and improved patient outcomes.
Based on region, Asia Pacific is growing exponentially in the acute care syndromic testing market due to rising healthcare investments, increasing prevalence of infectious diseases, and growing demand for rapid diagnostics. Countries like China, India, and South Korea are expanding their diagnostic infrastructure, while governments push for early disease detection and control. The rising adoption of multiplex molecular tests and growing public-private healthcare collaborations are further accelerating market growth in the region.
Some of the major companies operating in the Global
Acute Care Syndromic Testing Market include:
- Abbott
Laboratories
- Becton,
Dickinson and Company
- Biocartis NV
- bioMerieux SA
(BioFire Diagnostics)
- Danaher
Corporation (Cepheid, Inc.)
- DiaSorin S.p.A
(Luminex Corporation)
- Eurofins
Scientific (Eurofins Viracor)
- Hologic Inc.
- Laboratory
Corporation of America Holdings.
- QIAGEN N.V.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“Certain regions, particularly the North
America, are projected to exert significant demand for dyes worldwide. The
growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhancing their Testing Technologies each
year, are expected to contribute to a remarkable growth of the Global Dyes
Market in the forecast period," said Mr. Karan Chechi, Research Director
of TechSci Research, a research-based Global management consulting firm.
"Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Others), By Target (Bacteria, Viruses, Fungi, Parasites), By Sample Type (Blood, Urine, Biofluids, Stool, Swabs, Others), By End User (Hospitals, Clinical and Diagnostic Laboratories, Research and Academic Institutions, Others), By Region and Competition, 2020-2030F," has evaluated the future growth potential of
Global Acute Care Syndromic Testing Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Acute Care Syndromic Testing Market.
Contact
TechSci
Research LLC
420 Lexington
Avenue,
Suite 300, New
York,
United States-
10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com